The Phase 1 study is a randomized, double-blind, placebo-controlled, dose-escalation trial carried out in China, designed to evaluate the safety, tolerability, pharmacokinetics (PK), and ...

Researchers sought to determine the acute cardiovascular effects of amphetamine-dextroamphetamine use in healthy people free of ADHD. Study volunteers showed increases in blood pressure, heart rate, ...

TrumpRx was unveiled this month as part of an effort to foster a more competitive marketplace for prescription drugs.

Insulet Stock: why GLP-1 fears are overblown, with growth driven by Europe/MENA expansion. Read here for a detailed analysis on PODD stock.

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...

DMT's compressed psychedelic experience — just 20 to 30 minutes — is producing rapid, sustained drops in depression scores in clinical trials, and it may represent something more radical than a new ...

CagriSema posts 20.2% weight loss versus 23.6% for tirzepatide, prompting multiple downgrades and intensifying scrutiny ahead of 2032 patent cliffs.

Informational consumer guide examines Zealthy's online ED treatment model, sublingual Hardies formulations, provider evaluation process, subscription structure, and compounded medication disclosures ...

February was full of shocking twists, dramatic turns, and unforgettable moments across all five daytime soaps. From the high-stakes drama of Willow's (Katelyn MacMullen) revenge on Drew (Cameron ...

Ana Lisa Tavares, Clinical Lead for Rare Disease Research at Genomics England, shares her thoughts on the 'hype and hope' ...

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q4 2025 Earnings Call Transcript February 24, 2026 Kiniksa Pharmaceuticals, Ltd.

Day One Biopharmaceuticals, Inc. is rated Buy with net product revenues of $52.8M, up 36% from the prior quarter. Read more ...